Filing Flows › Chemed (CHE) › Capital expenditures
Chemed (CHE) capital expenditures by quarter
Chemed's capital expenditures were $18.7M in Q3 2026 (third quarter 2026), +21% from Q2 2026. Over the last 7 quarters it ranged from $13.8M (Q1 2025) to $37.9M (Q1 2026).
| Quarter | Capital expenditures | Q/Q | Y/Y |
|---|---|---|---|
| Q3 2026 | $18.7M | +21% | +7% |
| Q2 2026 | $15.5M | -59% | -2% |
| Q1 2026 | $37.9M | +126% | +175% |
| Q4 2025 | $16.8M | -4% | — |
| Q3 2025 | $17.5M | +11% | — |
| Q2 2025 | $15.8M | +15% | — |
| Q1 2025 | $13.8M | — | — |
Q3 2026 at a glance
Chemed, Q3 2026: revenue $691M (+11% year over year), operating margin 14.0%, net earnings $71.6M, operating cash flow $56.6M. The chart follows the revenue to costs, profit and cash.
Questions
What is Chemed's capital expenditures?
Chemed's capital expenditures were $18.7M in Q3 2026 (third quarter 2026), +21% from Q2 2026.
How has Chemed's capital expenditures changed?
Over the last 7 quarters it ranged from $13.8M (Q1 2025) to $37.9M (Q1 2026).